Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia
Hereditary hemorrhagic telangiectasia (HHT) is mechanistically and therapeutically challenging, not only because of the molecular and cellular perturbations that generate vascular abnormalities, but also the modifications to circulatory physiology that result, and are likely to exacerbate vascular i...
Main Author: | Claire L Shovlin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-04-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fgene.2015.00101/full |
Similar Items
-
Predictors of mortality in patients with hereditary hemorrhagic telangiectasia
by: K. P. Thompson, et al.
Published: (2021-01-01) -
Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia
by: Elisabetta Buscarini, et al.
Published: (2019-02-01) -
Gender differences in hereditary hemorrhagic telangiectasia severity
by: J. M. Mora-Luján, et al.
Published: (2020-03-01) -
Hereditary hemorrhagic telangiectasia and pregnancy: potential adverse events and pregnancy outcomes
by: Bari O, et al.
Published: (2017-05-01) -
A rare case of pulmonary arterio-venous malformation with recurrent anemia: Hereditary hemorrhagic telangiectasia
by: Kamalesh Tagadur Nataraju, et al.
Published: (2015-01-01)